|
DRMAW Dermata Therapeutics Inc 1853816 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,847,706.00 |
| Balance Sheet |
|
Assets
|
$7,465,652.00 |
|
Liabilities
|
$1,052,649.00 |
|
Equity
|
$6,413,003.00 |
|
Shares Out
|
4022143.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,479,718.00 |
| Market Analysis |
Market Cap
|
$40,221.43 |
|
Price
|
$0.01 |
|
BVPS
|
1.59 |
|
PB
|
0.01 |
|
EPS
|
-0.48 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:04 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DRMAW documents filed with the SEC.
DRMAW Filings
Clear
